Selvaggio Piera, Taci Esi, Barassi Alessandra, Massa Valentina, Gervasini Cristina, Lesma Elena, Bernardelli Clara, Di Fede Elisabetta
Department of Health Sciences, University of Milan, Via Antonio di Rudinì 8, Milano, Italy.
"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Orphanet J Rare Dis. 2025 Sep 1;20(1):465. doi: 10.1186/s13023-025-03778-1.
Cellular senescence is a biological process in which the cell cycle is arrested in response to DNA damage caused by different endogenous and exogenous stimuli. In senescent cells, activation of intracellular cascade induces epigenetic, morphological and metabolic changes. Among them, senescent status is characterized by an alteration of the epigenome and the establishment of a peculiar senescence-associated secretory phenotype (SASP), which contributes to the extracellular matrix remodeling and senescence spreading. Growing interest is directed towards senescence relevance both in physiological processes and in pathological ones, including rare progeroid syndromes. However, little is known about senescence contribution to the onset and development of rare diseases in which aging traits are not manifested.
Here, we review the current knowledge about senescence involvement in four rare mendelian disorders of the epigenetic machinery (i.e. chromatinopathies) and four rare lung diseases, that can be considered a paradigm for understanding how epigenome alteration and aberrant microenvironment modification in senescence process might drive disease onset and progression. First, we report the main characteristics of chromatinopathies and the relation between the chromatin-related epigenetic defects and the senescence features in Sotos syndrome, Cornelia de Lange syndrome, Rett syndrome, and Kleefstra syndromes. Thereafter, we describe the pathological alteration and senescence involvement in cystic fibrosis, idiopathic pulmonary fibrosis, pulmonary arterial hypertension and lymphangioleiomyomatosis, considering them as models of rare lung diseases in which accumulation of senescent cells and their proinflammatory SASP have a central role.
Exploring the role of senescence in different and less common diseases might promote the understanding of the senescent process as a novel player in rare disorders, for a more comprehensive vision of their complexity and the suggestion of novel possible therapeutical targets.
细胞衰老为一种生物学过程,其中细胞周期因不同内源性和外源性刺激导致的DNA损伤而停滞。在衰老细胞中,细胞内级联反应的激活诱导表观遗传、形态和代谢变化。其中,衰老状态的特征是表观基因组的改变以及特殊衰老相关分泌表型(SASP)的形成,这有助于细胞外基质重塑和衰老扩散。人们越来越关注衰老在生理过程和病理过程中的相关性,包括罕见的早衰综合征。然而,对于衰老在未表现出衰老特征的罕见疾病的发生和发展中的作用知之甚少。
在此,我们综述了目前关于衰老参与四种罕见的表观遗传机制孟德尔疾病(即染色质病)和四种罕见肺部疾病的知识,这些疾病可被视为理解衰老过程中的表观基因组改变和异常微环境修饰如何驱动疾病发生和进展的范例。首先,我们报告了染色质病的主要特征,以及索托斯综合征、科妮莉亚·德·朗格综合征、雷特综合征和克莱夫斯特拉综合征中与染色质相关的表观遗传缺陷与衰老特征之间的关系。此后,我们将囊性纤维化、特发性肺纤维化、肺动脉高压和淋巴管平滑肌瘤病视为罕见肺部疾病的模型,描述了其中的病理改变和衰老参与情况,在这些疾病中衰老细胞及其促炎SASP的积累起着核心作用。
探索衰老在不同和较罕见疾病中的作用,可能有助于将衰老过程理解为罕见疾病中的一个新因素,从而更全面地认识其复杂性,并为新的潜在治疗靶点提供建议。